We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Galenica AG (GALE) CHF0.1

Sell:69.20 CHF Buy:72.00 CHF Change: 0.35 CHF (0.50%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:69.20 CHF
Buy:72.00 CHF
Change: 0.35 CHF (0.50%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:69.20 CHF
Buy:72.00 CHF
Change: 0.35 CHF (0.50%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Contact details

Address:
Untermattweg 8
BERN
3027
Switzerland
Telephone:
+ ()
Website:
https://www.galenica.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GALE
ISIN:
CH0360674466
Market cap:
3.49 billion CHF
Shares in issue:
49.83 million
Sector:
Health Care Distributors
Exchange:
SIX Swiss Exchange
Country:
Switzerland
Currency:
Swiss Franc
Indices:
Swiss All Share Index

Key personnel

  • Marc Werner
    Chief Executive Officer, Member of the Corporate Executive Committee
  • Felix Burkhard
    Chief Financial Officer, Member of the Corporate Executive Committee
  • Arianne Hasler
    Chief People and Culture Officer, Member of the Corporate Executive Committee
  • Lukas Ackermann
    Chief IT & Digital Services Officer, Member of the Corporate Executive Committee
  • Virginie Jeschka
    Chief Pharmacies Officer, Member of the Corporate Executive Committee
  • Andreas Koch
    Head of Wholesale & Logistics, Member of the Corporate Executive Committee
  • Daniele Madonna
    Chief Healthcare Officer, Member of the Corporate Executive Committee
  • Thomas Szuran
    Chief Products & Marketing Officer, Member of the Corporate Executive Committee
  • Barbara Walchli
    General Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.